The reversible P2Y12 antagonist ACT-246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat.
about
The reversible P2Y12 antagonist ACT-246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The reversible P2Y12 antagonis ...... ntithrombotic efficacy in rat.
@en
The reversible P2Y12 antagonis ...... ntithrombotic efficacy in rat.
@nl
type
label
The reversible P2Y12 antagonis ...... ntithrombotic efficacy in rat.
@en
The reversible P2Y12 antagonis ...... ntithrombotic efficacy in rat.
@nl
prefLabel
The reversible P2Y12 antagonis ...... ntithrombotic efficacy in rat.
@en
The reversible P2Y12 antagonis ...... ntithrombotic efficacy in rat.
@nl
P2093
P2860
P356
P1476
The reversible P2Y12 antagonis ...... ntithrombotic efficacy in rat.
@en
P2093
Beat Steiner
Edgar Weber
Eva Caroff
Francis Hubler
Franck Haag
Keith Morrison
Markus A Riederer
Markus Kramberg
Markus Rey
Martine Baumann
P2860
P356
10.1002/PRP2.338
P577
2017-10-01T00:00:00Z